Gong Zhen, Hu Guoping, Li Qiang, Liu Zhiguo, Wang Fei, Zhang Xuejin, Xiong Jian, Li Peng, Xu Yan, Ma Rujian, Chen Shuhui, Li Jian
State Key Laboratory of Lead Compound Research, WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131. China.
Curr Drug Discov Technol. 2017;14(4):216-228. doi: 10.2174/1570163814666170425155154.
Hit identification is the starting point of small-molecule drug discovery and is therefore very important to the pharmaceutical industry. One of the most important approaches to identify a new hit is to screen a compound library using an in vitro assay. High-throughput screening has made great contributions to drug discovery since the 1990s but requires expensive equipment and facilities, and its success depends on the size of the compound library. Recent progress in the development of compound libraries has provided more efficient ways to identify new hits for novel drug targets, thereby helping to promote the development of the pharmaceutical industry, especially for firstin- class drugs.
A multistage and systematic research of articles published between 1986 and 2017 has been performed, which was organized into 5 sections and discussed in detail.
In this review, the sources and classification of compound libraries are summarized. The progress made in combinatorial libraries and DNA-encoded libraries is reviewed. Library design methods, especially for focused libraries, are introduced in detail. In the final part, the status of the compound libraries at WuXi is reported.
The progress related to compound libraries, especially drug template libraries, DELs, and focused libraries, will help to identify better hits for novel drug targets and promote the development of the pharmaceutical industry. Moreover, these libraries can facilitate hit identification, which benefits most research organizations, including academics and small companies.
靶点识别是小分子药物发现的起点,因此对制药行业非常重要。识别新靶点的最重要方法之一是使用体外试验筛选化合物库。自20世纪90年代以来,高通量筛选为药物发现做出了巨大贡献,但需要昂贵的设备和设施,其成功与否取决于化合物库的规模。化合物库开发的最新进展为识别新型药物靶点的新靶点提供了更有效的方法,从而有助于推动制药行业的发展,尤其是对首创药物而言。
对1986年至2017年发表的文章进行了多阶段、系统的研究,该研究分为5个部分并进行了详细讨论。
在本综述中,总结了化合物库的来源和分类。回顾了组合库和DNA编码库取得的进展。详细介绍了库设计方法,特别是针对聚焦库的方法。在最后一部分,报告了药明康德的化合物库状况。
与化合物库相关的进展,特别是药物模板库、DNA编码库和聚焦库,将有助于为新型药物靶点识别更好的靶点,并促进制药行业的发展。此外,这些库可以促进靶点识别,这对包括学术界和小公司在内的大多数研究机构都有益处。